Are randomized controlled trials sufficient evidence to guide clinical practice in Type II (non-insulin-dependent) diabetes mellitus? (original) (raw)

Abstract

Randomized controlled trials (RCTs) are often considered the standard for defining the practice of evidence-based medicine. Taken alone, they are, however, often insufficient to guide clinical care. Randomized controlled trials are clearly the best method to determine whether interventions are efficacious. They have, however, numerous limitations which make them difficult to carry out or limit applicability to routine clinical practice. Although observational studies also have inherent limitations, they provide data which can help to further explain the results of randomized controlled trials. The use of observational studies to frame randomized trials can allow better application of randomized controlled trial results to individual patients and can thus help to optimize delivery of care, inform clinical practice and determine the need for further such trials.

Article PDF

Similar content being viewed by others

Author information

Authors and Affiliations

1. The Veterans Affairs Center for Practice Management and Outcomes Research, Ann Arbor, Michigan, USA, , , , , , US
   S. Vijan & R. A. Hayward
2. The Robert Wood Johnson Clinical Scholars Program, University of Michigan, USA, , , , , , US
   D. M. Kent

Authors

1. S. Vijan
   You can also search for this author inPubMed Google Scholar
2. D. M. Kent
   You can also search for this author inPubMed Google Scholar
3. R. A. Hayward
   You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Vijan, S., Kent, D. & Hayward, R. Are randomized controlled trials sufficient evidence to guide clinical practice in Type II (non-insulin-dependent) diabetes mellitus?.Diabetologia 43, 125–130 (2000). https://doi.org/10.1007/s001250050017

Download citation

• Issue Date: January 2000
• DOI: https://doi.org/10.1007/s001250050017

Keywords